D609 Suppresses Antituberculosis Response by Regulating Dendritic Cells Antigen Presentation
2024

D609 and Its Role in Tuberculosis Immune Response

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Liu Honglin, Huang Huimin, Huang Zhen, Chen Yingxuan, Tan Deyou, Wang Xiaoni, Pang Xiaoni, Chen Shuwen, Liang Lianhui, Yang Haihui

Primary Institution: Zhongshan Second People's Hospital

Hypothesis

What is the role of phosphatidylcholine‐specific phospholipase C (PC‐PLC) in the antituberculosis immune response mediated by dendritic cells?

Conclusion

D609 inhibits the immune response against Mycobacterium tuberculosis by affecting dendritic cell function.

Supporting Evidence

  • D609-treated mice showed increased bacterial load and tissue damage.
  • D609 reduced the number of dendritic cells and their ability to activate T cells.
  • D609 inhibited the production of pro-inflammatory cytokines in dendritic cells.
  • D609 impaired antigen phagocytosis and processing in dendritic cells.
  • D609 treatment led to decreased T cell activation and proliferation.

Takeaway

D609 is a compound that can weaken the body's defense against tuberculosis by making it harder for immune cells to do their job.

Methodology

Mice were infected with Mycobacterium tuberculosis and treated with D609 to assess its effects on immune response and dendritic cell function.

Limitations

The study primarily used a mouse model, which may not fully replicate human responses.

Participant Demographics

C57BL/6J mice were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/iid3.70103

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication